Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,600 | 89,800 | 70,500 | 90,300 | 97,000 |
| Receivables | 103,000 | 103,800 | 111,500 | 110,200 | 104,800 |
| Inventories | 141,300 | 148,000 | 150,600 | 142,700 | 138,100 |
| TOTAL | $325,000 | $355,400 | $351,400 | $356,000 | $352,400 |
| Non-Current Assets | |||||
| PPE Net | 111,200 | 113,400 | 115,400 | 114,300 | 109,800 |
| Intangibles | 508,700 | 512,700 | 516,400 | 486,600 | 563,100 |
| Other Non-Current Assets | 105,200 | 92,200 | 84,500 | 82,100 | 82,500 |
| TOTAL | $725,100 | $718,300 | $716,300 | $683,000 | $755,400 |
| Total Assets | $1,050,100 | $1,073,700 | $1,067,700 | $1,039,000 | $1,107,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,900 | 10,200 | 9,400 | 9,400 | 9,400 |
| Accounts payable and accrued liabilities | 52,300 | 55,500 | 54,200 | 48,800 | 46,000 |
| Accrued Expenses | 57,600 | 91,300 | 74,800 | 66,000 | 71,400 |
| TOTAL | $131,200 | $165,200 | $147,900 | $134,600 | $137,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 87,300 | 90,300 | 93,400 | 95,700 | 98,000 |
| Other Non-Current Liabilities | 43,900 | 33,900 | 42,100 | 26,100 | 27,600 |
| TOTAL | $136,800 | $130,300 | $141,800 | $128,100 | $131,200 |
| Total Liabilities | $268,000 | $295,500 | $289,700 | $262,700 | $268,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,825 | 46,503 | 46,419 | 46,402 | 46,244 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -774,800 | -779,900 | -778,600 | -777,200 | -700,400 |
| Other shareholders' equity | -35,600 | -32,300 | -32,600 | -31,900 | -42,500 |
| TOTAL | $782,100 | $778,200 | $778,000 | $776,300 | $839,400 |
| Total Liabilities And Equity | $1,050,100 | $1,073,700 | $1,067,700 | $1,039,000 | $1,107,800 |